Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy.
Badarni M, Prasad M, Balaban N, Zorea J, Yegodayev KM, Joshua BZ, Dinur AB, Grénman R, Rotblat B, Cohen L, Elkabets M.
Badarni M, et al. Among authors: balaban n.
JCI Insight. 2019 Mar 12;5(8):e125341. doi: 10.1172/jci.insight.125341.
JCI Insight. 2019.
PMID: 30860495
Free PMC article.